Polysaccharide storage myopathy in canine phosphofructokinase deficiency (type VII glycogen storage disease).
A severe, progressive myopathy developed in an 11-year-old, phosphofructokinase (PFK)-deficient, male, English Springer Spaniel dog. Results from a routine neurological examination were normal. Examination of histologic sections of skeletal muscle revealed large accumulations of material in some myofibers. These deposits were pale, basophilic, somewhat flocculent, and slightly granular with hematoxylin and eosin stain. Most fascicles examined in sections of limb and trunk muscles were affected to some degree, with up to 10% of muscle fibers being involved. Deposits stained strongly with periodic acid-Schiff and were resistant to digestion by alpha amylase but were removed by incubation with gamma amylase. Deposits were faintly positive with Gomori's methenamine silver technique and alcian blue (pH 2.5) and were brown-gray with Lugol's iodine solution but were negative with other stains. Based on staining characteristics, the deposits seemed to consist primarily of an amylopectin-like polysaccharide(s). Alcian blue staining (pH 2.5) was removed by treatment with neuraminidase but not with hyaluronidase, indicating that some sialic acid residues were also present. Electron microscopically, the deposits were composed of short granular filaments, small granules and amorphous material. They were not membrane bound. The morphologic appearance and staining characteristics of the deposits were remarkably similar to deposits previously described in human PFK-deficient myopathy. As expected, total PFK activities were markedly reduced when assayed in skeletal muscles of this dog. In contrast with other PFK-deficient dogs, muscle glycogen in this animal was not increased above that of normal dogs.
Harvey
J W
JW
Department of Physiological Sciences, College of Veterinary Medicine, University of Florida, Gainesville.
Calderwood Mays
M B
MB
Gropp
K E
KE
Denaro
F J
FJ
D000818:Animals; D001284:Atrophy; D004283:Dog Diseases / Q000473:pathology*; D004285:Dogs; D006003:Glycogen / Q000032:analysis; D006008:Glycogen Storage Disease / Q000662:veterinary*; D006014:Glycogen Storage Disease Type VII / Q000473:pathology / Q000662:veterinary*; D008297:Male; D008854:Microscopy, Electron; D009132:Muscles / Q000032:analysis / Q000473:pathology* / Q000648:ultrastructure; D010732:Phosphofructokinase-1 / Q000032:analysis / Q000172:deficiency*; D011134:Polysaccharides / Q000032:analysis; D013163:Splenomegaly / Q000662:veterinary
D011134:Polysaccharides; D006003:Glycogen; D010732:Phosphofructokinase-1